Fennec Pharmaceuticals Inc Asset Turnover Ratio (FENC), as of first quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Fennec Pharmaceuticals Inc   (NASDAQ: FENC)
 

Fennec Pharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the first quarter 2026, Fennec Pharmaceuticals Inc 's asset turnover ratio sequentially decreased to 0.56 in the first quarter (Mar 31 2026), this is lower than usual.

Within sector 51 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the I Quarter 2026, to 2663, from total ranking in the fourth quarter 2025 at 2706.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

FENC Asset Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Asset Change 65.4 % 50.13 % 21.29 % 1.03 % 1.61 %
Y / Y Revenue Change 72.64 % 73.84 % 78.69 % 32.91 % -65.52 %
Asset Turnover Ratio (TTM) 0.56 0.57 0.56 0.5 0.47
FENC's Total Ranking # 2663 # 2706 # 0 # 0 # 0
Seq. Asset Change 5.5 % 54.19 % 11.99 % -9.21 % -4.25 %
Seq. Revenue Change 9.66 % 10.55 % 29.11 % 10.3 % 10.42 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 52
Healthcare Sector # 449
Overall Market # 2663

Asset Turnover Ratio Statistics
High Average Low
5.12 3.36 2.36
(Sep 30 2023)   (Dec 31 2025)




FENC Company Profile • Back to FENC Efficiency Comparisons • Compare FENC Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Assets at quarter ending Mar 31 2026
Rockwell Medical inc   1.20 $ 67.550  Millions$ 56.170  Millions
Henry Schein Inc   1.20 $ 13,384.000  Millions$ 11,130.500  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  1.20 $ 20.577  Millions$ 17.200  Millions
The Pennant Group Inc   1.19 $ 1,023.227  Millions$ 857.430  Millions
Lifeloc Technologies Inc   1.19 $ 9.044  Millions$ 7.588  Millions
Universal Health Services Inc   1.19 $ 18,292.509  Millions$ 15,384.559  Millions
Myriad Genetics Inc   1.19 $ 828.000  Millions$ 696.425  Millions
Exagen Inc   1.17 $ 67.881  Millions$ 57.890  Millions
Precision Optics Corporation Inc   1.17 $ 28.939  Millions$ 24.689  Millions
Sunshine Biopharma Inc   1.17 $ 35.493  Millions$ 30.366  Millions
Inogen Inc   1.17 $ 351.497  Millions$ 300.900  Millions
Lftd Partners Inc   1.17 $ 36.955  Millions$ 31.687  Millions
Natera Inc   1.16 $ 2,500.927  Millions$ 2,147.823  Millions
Nuwellis Inc   1.16 $ 8.769  Millions$ 7.566  Millions
Tela Bio Inc   1.15 $ 80.349  Millions$ 70.108  Millions
Angiodynamics Inc   1.15 $ 311.277  Millions$ 271.652  Millions
Mettler toledo International Inc   1.14 $ 4,089.782  Millions$ 3,575.873  Millions
Pro dex Inc   1.14 $ 74.636  Millions$ 65.681  Millions
Puma Biotechnology Inc   1.13 $ 227.178  Millions$ 201.695  Millions
Myomo Inc   1.11 $ 41.180  Millions$ 37.035  Millions
Hims and Hers Health Inc   1.11 $ 2,369.476  Millions$ 2,133.159  Millions
Neuronetics Inc   1.10 $ 150.724  Millions$ 136.777  Millions
Apellis Pharmaceuticals Inc   1.09 $ 1,105.280  Millions$ 1,009.475  Millions
Tarsus Pharmaceuticals Inc   1.09 $ 589.621  Millions$ 543.212  Millions
Longduoduo Co Ltd  1.08 $ 2.132  Millions$ 1.969  Millions
Tandem Diabetes Care Inc   1.08 $ 1,023.420  Millions$ 946.224  Millions
Phibro Animal Health Corporation  1.08 $ 1,500.123  Millions$ 1,388.110  Millions
Harvard Bioscience Inc   1.08 $ 84.970  Millions$ 79.024  Millions
Biodesix Inc   1.07 $ 96.096  Millions$ 89.644  Millions
Inspire Medical Systems inc   1.07 $ 915.060  Millions$ 857.151  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.